Role of Galectins in Multiple Myeloma

Role of Galectins in Multiple Myeloma

Galectins are a family of lectins that bind β-galactose-containing glycoconjugates and are characterized by carbohydrate-recognition domains (CRDs). Galectins exploit several biological functions, including angiogenesis, regulation of immune cell activities and cell adhesion, in both physiological a...

Full description

Bibliographic Details
Main Authors:	Paola Storti, Valentina Marchica, Nicola Giuliani
Format:	Article
Language:	English
Published:	MDPI AG 2017-12-01
Series:	International Journal of Molecular Sciences
Subjects:	galectins myeloma galectin-1 galectin-3 galectin-8 galectin-9
Online Access:	https://www.mdpi.com/1422-0067/18/12/2740

Similar Items

A unique maternal and placental galectin signature upon SARS-CoV-2 infection suggests galectin-1 as a key alarmin at the maternal–fetal interface
by: Fangqi Zhao, et al.
Published: (2023-07-01)

The role of salivary galectin-3 and galectin-9 levels in plaque-induced gingivitis and periodontitis
by: Zerrin Barut, et al.
Published: (2023-09-01)

Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials
by: Daniel Compagno, et al.
Published: (2020-05-01)

Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
by: Fei Kong, et al.
Published: (2020-09-01)

Galectin 3: an extraordinary multifunctional protein in dermatology. Current knowledge and perspectives
by: Efstathia Pasmatzi, et al.
Published: (2019-07-01)

Pattern Analysis of Serum Galectins-1, -3, and -9 in Breast Cancer
by: Avery Funkhouser, et al.
Published: (2023-07-01)

High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients
by: Anna Trebo, et al.
Published: (2020-04-01)

PRP as a modulator of inflammation in FLS of RA patients by regulation of galectins and TGF-β1
by: Shourangiz Piramoon, et al.
Published: (2024-01-01)

Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications
by: Julia Nowowiejska, et al.
Published: (2023-09-01)

Serum Galectin‐1, Galectin‐9, and YKL‐40 levels in bipolar disorder and their relationship with cognitive functions
by: Elcicek Selahaddin, et al.
Published: (2024-02-01)

Clinical Relevance of Galectin-1 and Galectin-3 in Rheumatoid Arthritis Patients: Differential Regulation and Correlation With Disease Activity
by: Santiago P. Mendez-Huergo, et al.
Published: (2019-01-01)

Novel Galectin-3 Roles in Neurogenesis, Inflammation and Neurological Diseases
by: Luana C. Soares, et al.
Published: (2021-11-01)

Placental galectin-3 is reduced in early-onset preeclampsia
by: Manju Kandel, et al.
Published: (2022-10-01)

Galectins as Cancer Biomarkers
by: Vitaly Balan, et al.
Published: (2010-04-01)

Galectins Are Central Mediators of Immune Escape in Pancreatic Ductal Adenocarcinoma
by: Zhengting Jiang, et al.
Published: (2022-11-01)

Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts
by: Joséphine Muller, et al.
Published: (2019-02-01)

The Complex Biological Effects of Pectin: Galectin-3 Targeting as Potential Human Health Improvement?
by: Lucas de Freitas Pedrosa, et al.
Published: (2022-02-01)

Endogenous Galectin-1 Modulates Cell Biological Properties of Immortalized Retinal Pigment Epithelial Cells In Vitro
by: Caspar Liesenhoff, et al.
Published: (2023-08-01)

Placental Galectins in Cancer: Why We Should Pay More Attention
by: Camille Fuselier, et al.
Published: (2023-01-01)

Characterization of Galectin Fusion Proteins with Glycoprotein Affinity Columns and Binding Assays
by: Carina Dey, et al.
Published: (2023-01-01)

Increased Expression of Galectin-3 in Skin Fibrosis: Evidence from In Vitro and In Vivo Studies
by: Teresa Peiró, et al.
Published: (2022-12-01)

Promoter methylation might shift the balance of Galectin-3 & 12 expression in de novo adult acute myeloid leukemia patients
by: Magda Assem, et al.
Published: (2023-02-01)

Galectin-3 Is a Natural Binding Ligand of MCAM (CD146, MUC18) in Melanoma Cells and Their Interaction Promotes Melanoma Progression
by: Yaoyu Pang, et al.
Published: (2022-10-01)

Inhibition of galectins in cancer: Biological challenges for their clinical application
by: Diego José Laderach, et al.
Published: (2023-01-01)

A Survey of interval training on the expression of ICAM, VCAM and galectin-3 proteins in the heart tissue of asthmatic rats
by: Masome Nobahar, et al.
Published: (2021-10-01)

Galectins as pivotal components in oncogenesis and immune exclusion in human malignancies
by: Nikiforos-Ioannis Kapetanakis, et al.
Published: (2023-02-01)

Galectin-3: Roles in Neurodevelopment, Neuroinflammation, and Behavior
by: Ivan Srejovic, et al.
Published: (2020-05-01)

Serum Galectin-3 levels and all-cause and cardiovascular mortality in maintenance hemodialysis patients: a prospective cohort study
by: Shuxin Liu, et al.
Published: (2022-01-01)

Galectin-1 and Galectin-3 in B-Cell Precursor Acute Lymphoblastic Leukemia
by: Fei Fei, et al.
Published: (2022-11-01)

Exploring the Molecular Interactions of Symmetrical and Unsymmetrical Selenoglycosides with Human Galectin-1 and Galectin-3
by: Luciano Pirone, et al.
Published: (2022-07-01)

Galectins in Equine Placental Disease
by: Carleigh E. Fedorka, et al.
Published: (2023-03-01)

Galectin-1 and Galectin-9 Concentration in Maternal Serum: Implications in Pregnancies Complicated with Preterm Prelabor Rupture of Membranes
by: Dorota Grażyna Boroń, et al.
Published: (2022-10-01)

A potential role for Galectin-3 inhibitors in the treatment of COVID-19
by: John L. Caniglia, et al.
Published: (2020-06-01)

Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Letter]
by: Panjaitan NSD, et al.
Published: (2022-11-01)

Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Response to Letter]
by: Reyes-Vallejo T, et al.
Published: (2022-12-01)

Galectin-9 in Gastroenterological Cancer
by: Asahiro Morishita, et al.
Published: (2023-03-01)

Sex‐specific associations of cardiorespiratory fitness and galectin‐3 in the general population
by: Magdalena E. Haid, et al.
Published: (2022-12-01)

Galectin-3 in Kidney Diseases: From an Old Protein to a New Therapeutic Target
by: Louis Boutin, et al.
Published: (2022-03-01)

Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia
by: Somayeh S. Tarighat, et al.
Published: (2021-11-01)

Genetic targeting or pharmacological inhibition of galectin-3 dampens microglia reactivity and delays retinal degeneration
by: Mona Tabel, et al.
Published: (2022-09-01)